Corrigendum to: Low Expression MCEMP1 Promotes Lung Adenocarcinoma Progression and its Clinical Value | Bentham Science Publishers

2000

Volume 25, Issue 6

ISSN: 1568-0096
E-ISSN: 1873-5576

f Corrigendum to: Low Expression MCEMP1 Promotes Lung Adenocarcinoma Progression and its Clinical Value
Authors: Liqun Ling¹, Tianqi Hu¹, Chenkang Zhou¹, Shuhui Chen¹, Lunan Chou¹, Yuxin Chen¹, Zhaoting Hu¹, Kate Huang², Jie Chen³, Yumin Wang^1,4 and Junjun Wang¹
View Affiliations Hide Affiliations

¹ Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015, China ; ² Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015, China ; ³ Department of ICU, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015, China ; ⁴ Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou, 325015, China
Source: Current Cancer Drug Targets, Volume 25, Issue 6, Jun 2025, p. 680 - 680
DOI: https://doi.org/10.2174/1568009625999250210092856
- Available online: 10 Feb 2025

There is no abstract available.

© 2025 Bentham Science Publishers

Article metrics loading...

/content/journals/ccdt/10.2174/1568009625999250210092856

2025-02-10

2025-10-26

From This Site

/content/journals/ccdt/10.2174/1568009625999250210092856

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Loading full text...

Full text loading...

/deliver/fulltext/ccdt/25/6/CCDT-25-6-09.html?itemId=/content/journals/ccdt/10.2174/1568009625999250210092856&mimeType=html&fmt=ahah

References

LingL. HuT. ZhouC. Low Expression MCEMP1 promotes lung adenocarcinoma progression and its clinical value.Curr. Cancer Drug Targets2025253281293
[Google Scholar]

/content/journals/ccdt/10.2174/1568009625999250210092856

Article Type: Correction

Most Cited Most Cited RSS feed

- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
  
  Authors: Yong Lin, Ranxin Shi, Xia Wang and Han-Ming Shen
- The Role of Snail in EMT and Tumorigenesis
  
  Authors: Yifan Wang, Jian Shi, Kequn Chai, Xuhua Ying and Binhua P. Zhou
- The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
  
  Authors: Amancio Carnero, Carmen Blanco-Aparicio, Oliver Renner, Wolfgang Link and Juan F.M. Leal
- Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
  
  Authors: D. Chen, M. Frezza, S. Schmitt, J. Kanwar and Q. P. Dou
- P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
  
  Authors: Ziyad Binkhathlan and Afsaneh Lavasanifar
- Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action
  
  Authors: M. Abal, J.M. Andreu and I. Barasoain
- Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
  
  Authors: R.Z. Yusuf, Z. Duan, D.E. Lamendola, R.T. Penson and M.V. Seiden
- The Role of Fibroblast Growth Factors in Tumor Growth
  
  Authors: M. Korc and R. E. Friesel
- Garlic [Allium sativum]: A Review of its Potential Use as an Anti-Cancer Agent
  
  Authors: M. Thomson and M. Ali
- Oxidative Stress and Cancer: The Role of Nrf2
  
  Authors: Soraya Sajadimajd and Mozafar Khazaei
More Less

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error

Please enter a valid_number test